Too little, too late: ineffective regulation of dietary supplements in the United States.
Where this comes from
- Record sourced from PubMed, PMID 25602879.
- Also identified by DOI 10.2105/AJPH.2014.302348 and PMC identifier 4330859.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Millions of people in the United States consume dietary supplements hoping to maintain or improve their health; however, extensive research has failed to demonstrate the efficacy of numerous supplements in disease prevention. In addition, concerns about the safety of routine and high-dose supplementation have been raised. The Food and Drug Administration regulates dietary supplement quality, safety, and labeling, and the Federal Trade Commission monitors advertisements and marketing; still, vast enforcement challenges remain, and optimal governmental oversight has not been achieved. If the composition and quality of ingredients cannot be reliably ensured, the validity of research on dietary supplements is questionable. Moreover, the health of the US public is put at risk.
Medical subject headings
- Advertising
- Consumer Product Safety
- Dietary Supplements
- Marketing